Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Arletta Pharma Solutions Appoints Jeannette Jager Van Dijk As Chief Executive Officer

PRIVATESep 01, 2026•6 days ago

Position

Chief Executive Officer

Company

Arletta Pharma Solutions

Jeannette Jager-van Dijk
AmsterdamBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Arletta Pharma Solutions announces the appointment of Jeannette Jager-van Dijk as Chief Executive Officer, effective September 1, 2026. Her extensive experience in women's health and pharmaceutical leadership positions her to lead the company as it focuses on the U.S. market and the development of Lybrido™.

Company Information

Company

Arletta Pharma Solutions

Location

Amsterdam, North Holland, Netherlands

About

Arletta Pharma Solutions is a clinical-stage biopharmaceutical company developing innovative therapies for women with Female Sexual Disorders. They focus on bringing effective and well-tolerated treatments to market. The company aims to address critical needs in women's health, particularly for disorders like Female Sexual Interest/Arousal Disorder and Hypoactive Sexual Desire Disorder.

Don't miss Arletta Pharma Solutions's next move

Get an email the moment Arletta Pharma Solutions changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Arletta Pharma Solutions's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Arletta Pharma Solutions changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.